Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic

Patients with inflammatory diseases who receive moderate or high-risk anti-inflammatory therapies might be considered as an increased risk group for severe COVID-19 and appropriate measures should be taken in order to protect them. . Initiation of immuno-suppressive/modulatory therapies should be do...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mediterr J Rheumatol
Hlavní autoři: Apostolou, Theofanis, Koutroubakis, Ioannis E., Manolakopoulos, Spilios, Mantzaris, Gerasimos, Rigopoulos, Dimitrios, Triantafyllou, Konstantinos, Vassilopoulos, Dimitrios
Médium: Artigo
Jazyk:Inglês
Vydáno: The Mediterranean Journal of Rheumatology (MJR) 2020
Témata:
Joint Position Statement
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656124/
https://ncbi.nlm.nih.gov/pubmed/33196008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.3.295
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky